/ICO.ST
ICO.ST Stock - Iconovo AB (publ)
Healthcare|Medical - DevicesSTO
$1.14+2.25%
+$0.03 (+2.25%) • Dec 23
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.2
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ICO.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.12 – $1.15
TARGET (TP)$1.31
STOP LOSS$1.04
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.46
52W High$5.18
52W Low$1.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.93M | $7.08M | $17.12M | $15.41M | $17.79M |
| Gross Profit | $19.13M | $17.58M | $17.24M | $21.31M | $20.81M |
| Gross Margin | 652.1% | 248.3% | 100.7% | 138.3% | 117.0% |
| Operating Income | $-41,076,000 | $-45,777,000 | $-48,358,267 | $-26,497,750 | $-16,490,945 |
| Net Income | $-41,140,000 | $-45,893,831 | $-50,309,657 | $-26,160,589 | $-17,133,888 |
| Net Margin | -1402.2% | -648.4% | -293.9% | -169.8% | -96.3% |
| EPS | $-2.57 | $-4.39 | $-5.69 | $-3.15 | $-2.20 |
Company Overview
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius AB (publ) to develop inhalation product to treat COPD. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ICO.STBeat Rate
100%
Last 1 quarters
Avg Surprise
+67.9%
EPS vs Estimate
Beats / Misses
1/0
Last 12 quarters
Latest EPS
$-0.17
Q4 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2026 | Jul 8, 2026 | — | — | — | — |
Q2 2026 | Apr 22, 2026 | — | — | — | — |
Q1 2026 | Feb 16, 2026 | — | — | — | — |
Q4 2025 | Oct 24, 2025 | — | $-0.17 | — | — |
Q2 2025 | Apr 24, 2025 | — | $-0.53 | — | — |
Q1 2025 | Feb 27, 2025 | — | $-0.59 | — | — |
Q4 2024 | Oct 24, 2024 | — | $-0.70 | — | — |
Q3 2024 | Jul 12, 2024 | — | $-0.60 | — | — |
Q2 2024 | Apr 25, 2024 | — | $-0.69 | — | — |
Q1 2024 | Feb 16, 2024 | — | $-0.84 | — | — |
Q4 2023 | Oct 27, 2023 | — | $-0.97 | — | — |
Q3 2023 | Jul 14, 2023 | — | $-1.28 | — | — |
Q2 2023 | Apr 28, 2023 | — | $-1.37 | — | — |
Q1 2023 | Feb 8, 2023 | $-6.61 | $-2.12 | +67.9% | ✓ BEAT |
Q4 2022 | Oct 28, 2022 | — | $-1.14 | — | — |
Q3 2022 | Jul 15, 2022 | — | $-1.38 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-1.03 | — | — |
Q1 2022 | Feb 18, 2022 | — | $-1.04 | — | — |
Q4 2021 | Oct 28, 2021 | — | $-0.43 | — | — |
Q3 2021 | Aug 20, 2021 | — | $-0.86 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ICO.ST
What is ICO.ST's current stock price?
Iconovo AB (publ) (ICO.ST) is currently trading at $1.14 per share. The stock has moved +2.25% today.
What is the analyst price target for ICO.ST?
No analyst price targets are currently available for this stock.
What sector is Iconovo AB (publ) in?
Iconovo AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is ICO.ST's market cap?
Iconovo AB (publ) has a market capitalization of $0.06 billion, making it a small-cap company.
Does ICO.ST pay dividends?
No, Iconovo AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACTI.ST
Active Biotech AB (publ)
$0.04
Mkt Cap: $0.1B
ARCOMA.ST
Arcoma AB
$7.50
Mkt Cap: $0.1B
BIOVIC-B.ST
Biovica International AB (publ)
$0.34
Mkt Cap: $0.1B
HEART.ST
Scandinavian Real Heart AB (Publ)
$14.00
Mkt Cap: $0.1B
IDLDX.ST
IDL Diagnostics AB (publ)
$0.35
Mkt Cap: $0.1B
IMMNOV.ST
Immunovia AB (publ)
$0.23
Mkt Cap: $0.1B
LXB.ST
Luxbright AB (publ)
$0.45
Mkt Cap: $0.1B
PILA.ST
Pila Pharma AB (publ)
$2.20
Mkt Cap: $0.1B
SCIB.ST
SciBase Holding AB (publ)
$0.36
Mkt Cap: $0.1B
SPEC.ST
SpectraCure AB (publ)
$0.16
Mkt Cap: $0.1B
Explore stocks similar to ICO.ST for comparison